Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
Public ClinicalTrials.gov record NCT07566286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
Study identification
- NCT ID
- NCT07566286
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Galderma R&D
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Restylane Lyft with Lidocaine Device
Device
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2, 2026
- Primary completion
- Oct 31, 2027
- Completion
- Feb 27, 2028
- Last update posted
- Jun 30, 2026
2026 – 2028
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site # 8680 | Westport | Connecticut | 06880 | — |
| Galderma Investigational Site # 8774 | Boynton Beach | Florida | 33437 | — |
| Galderma Investigational Site # 7030 | Coral Gables | Florida | 33134 | — |
| Galderma Investigational Site # 8682 | Coral Gables | Florida | 33134 | — |
| Galderma Investigational Site # 7042 | Atlanta | Georgia | 30331 | — |
| Galderma Investigational Site # 7043 | Bethesda | Maryland | 20852 | — |
| Galderma Investigational Site # 7118 | Nashville | Tennessee | 37203 | — |
| Galderma Investigational Site # 8662 | Spring | Texas | 77388 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07566286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 30, 2026 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07566286 live on ClinicalTrials.gov.